IMMUTEP LIMITED - AMER
1.9400
21-5月-25 13:45:00
15 分の遅延
株式
-0.0700
-3.48%
本日の幅
1.8800 - 2.0252
ISIN
N/A
ソース
NASDAQ
-
Immutep Quarterly Activities Report & Appendix 4C
28 10 2021 05:00:02 提供 Nasdaq GlobeNewswire
-
Immutep to Present Phase II TACTI-002 Data at SITC 2021
01 10 2021 05:00:02 提供 Nasdaq GlobeNewswire
-
Immutep Receives A$3.4 million R&D Tax Incentive from French Government
29 9 2021 05:00:00 提供 Nasdaq GlobeNewswire
-
Immutep to Present at Healthcare Investor Conferences
28 9 2021 05:00:01 提供 Nasdaq GlobeNewswire
-
21 9 2021 05:38:03 提供 Nasdaq GlobeNewswire
-
Immutep Completes Recruitment of 2nd line PD-1/PD-L1 refractory NSCLC Patients in TACTI-002
01 9 2021 05:00:00 提供 Nasdaq GlobeNewswire
-
Immutep’s Chinese Partner, Eoc Pharma, Expands Efti Trial Pipeline
31 8 2021 05:00:01 提供 Nasdaq GlobeNewswire
-
Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525
27 8 2021 05:00:00 提供 Nasdaq GlobeNewswire
-
05 8 2021 05:00:02 提供 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
13 7 2021 05:00:03 提供 Nasdaq GlobeNewswire